Mojtaba Shafiekhani

568 total citations
51 papers, 336 citations indexed

About

Mojtaba Shafiekhani is a scholar working on Infectious Diseases, Nutrition and Dietetics and Surgery. According to data from OpenAlex, Mojtaba Shafiekhani has authored 51 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 11 papers in Nutrition and Dietetics and 7 papers in Surgery. Recurrent topics in Mojtaba Shafiekhani's work include COVID-19 Clinical Research Studies (9 papers), Clinical Nutrition and Gastroenterology (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Mojtaba Shafiekhani is often cited by papers focused on COVID-19 Clinical Research Studies (9 papers), Clinical Nutrition and Gastroenterology (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Mojtaba Shafiekhani collaborates with scholars based in Iran, Argentina and United States. Mojtaba Shafiekhani's co-authors include Afsaneh Vazin, Mahtabalsadat Mirjalili, Reza Heidari, Mohammad Mehdi Ommati, Negar Azarpira, Manica Negahdaripour, Iman Karimzadeh, Reza Shahriarirad, Soha Namazi and Dorna Davani-Davari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Transplantation.

In The Last Decade

Mojtaba Shafiekhani

45 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mojtaba Shafiekhani Iran 10 117 46 45 36 31 51 336
Fariba Samadian Iran 11 82 0.7× 96 2.1× 51 1.1× 14 0.4× 45 1.5× 30 426
Mojdeh S. Heavner United States 12 130 1.1× 65 1.4× 45 1.0× 70 1.9× 8 0.3× 59 491
Claudia Gregoriano Switzerland 12 110 0.9× 156 3.4× 42 0.9× 17 0.5× 41 1.3× 41 524
Anne Leuppi-Taegtmeyer Switzerland 11 62 0.5× 44 1.0× 23 0.5× 37 1.0× 18 0.6× 51 294
Erika Jones South Africa 13 56 0.5× 53 1.2× 71 1.6× 21 0.6× 71 2.3× 68 649
Jerry Altshuler United States 10 48 0.4× 68 1.5× 44 1.0× 90 2.5× 7 0.2× 24 278
Molouk Hadjibabaie Iran 11 39 0.3× 61 1.3× 34 0.8× 44 1.2× 19 0.6× 32 414
Emmett Tsz Yeung Wong Singapore 9 39 0.3× 51 1.1× 50 1.1× 17 0.5× 18 0.6× 23 374
Ali Taghizadeh Afshari Iran 11 31 0.3× 67 1.5× 61 1.4× 13 0.4× 22 0.7× 35 432
Shaun Eintracht Canada 13 72 0.6× 91 2.0× 46 1.0× 11 0.3× 138 4.5× 27 466

Countries citing papers authored by Mojtaba Shafiekhani

Since Specialization
Citations

This map shows the geographic impact of Mojtaba Shafiekhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojtaba Shafiekhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojtaba Shafiekhani more than expected).

Fields of papers citing papers by Mojtaba Shafiekhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojtaba Shafiekhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojtaba Shafiekhani. The network helps show where Mojtaba Shafiekhani may publish in the future.

Co-authorship network of co-authors of Mojtaba Shafiekhani

This figure shows the co-authorship network connecting the top 25 collaborators of Mojtaba Shafiekhani. A scholar is included among the top collaborators of Mojtaba Shafiekhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojtaba Shafiekhani. Mojtaba Shafiekhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anbardar, Mohammad Hossein, et al.. (2024). Disseminated Gastrointestinal Basidiobolomycosis: A Case Report with Review of Diagnostic Clues. SHILAP Revista de lepidopterología. 2024(1). 5741625–5741625. 2 indexed citations
2.
Karimzadeh, Iman, Mojtaba Shafiekhani, Reza Heidari, et al.. (2024). Protective effects of silymarin on preventing vancomycin nephrotoxicity in infectious patients: a randomized, double-blinded, placebo-controlled, pilot clinical trial. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(3). 2945–2960. 1 indexed citations
3.
Vazin, Afsaneh, et al.. (2024). Drug-related problems among pediatric intensive care units: prevalence, risk factors, and clinical pharmacists’ interventions. BMC Pediatrics. 24(1). 714–714. 2 indexed citations
4.
Shafiekhani, Mojtaba, et al.. (2023). Pharmacokinetic and Pharmacodynamic Considerations of Novel Antibiotic Agents for Pediatric Infections: A Narrative Review. Surgical Infections. 24(8). 703–715. 1 indexed citations
5.
Shafiekhani, Mojtaba, et al.. (2023). Antibiotic stewardship implementation at the largest solid organ transplantation center in Asia: a retrospective cohort study. BMC Surgery. 23(1). 81–81. 5 indexed citations
6.
Shafiekhani, Mojtaba, et al.. (2023). COVID-19 versus applied infection control policies in a Major Transplant Center in Iran. Cost Effectiveness and Resource Allocation. 21(1). 17–17. 4 indexed citations
7.
Shafiekhani, Mojtaba, et al.. (2023). Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study. Frontiers in Pharmacology. 14. 1051350–1051350. 5 indexed citations
8.
Khosravi, Mohammad Bagher, Mojtaba Shafiekhani, Alireza Shamsaeefar, et al.. (2022). Intestinal Transplantation in a Country Without Home Parenteral Nutrition: The Largest Report from the Middle East. The Turkish Journal of Gastroenterology. 33(9). 793–802. 3 indexed citations
9.
Jamshidzadeh, Akram, et al.. (2022). The effect of taurine supplementation on delirium post liver transplantation: A randomized controlled trial. Clinical Nutrition. 41(10). 2211–2218. 10 indexed citations
10.
11.
Shafiekhani, Mojtaba, et al.. (2021). Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?. Virology Journal. 18(1). 228–228. 21 indexed citations
12.
Zareshahrabadi, Zahra, et al.. (2021). Emerging of Fatal Colitis with Multidrug-Resistant Candida glabrata after Small Bowel Transplantation. SHILAP Revista de lepidopterología. 2021. 1–6.
13.
Mirjalili, Mahtabalsadat, Mojtaba Shafiekhani, & Afsaneh Vazin. (2020). Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen. SHILAP Revista de lepidopterología. 3 indexed citations
14.
Shafiekhani, Mojtaba, et al.. (2020). Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial. SHILAP Revista de lepidopterología.
15.
Moradi, Ali, Peyman Arasteh, Alireza Shamsaeefar, et al.. (2020). Guideline for Management of Mesenteric Ischemia: Shiraz Intestinal Failure Unit Protocol. Archives of Iranian Medicine. 23(6). 422–425. 4 indexed citations
16.
17.
Mahmoudi, Laleh, et al.. (2019). <p>Community pharmacists’ knowledge, attitude, and practice of Irritable Bowel Syndrome (IBS): the impact of training courses</p>. Advances in Medical Education and Practice. Volume 10. 427–436. 3 indexed citations
18.
Shafiekhani, Mojtaba, et al.. (2019). Glycine supplementation mitigates lead-induced renal injury in mice. SHILAP Revista de lepidopterología. 3 indexed citations
19.
Karimzadeh, Iman, et al.. (2019). <p>Pattern and associated factors of adherence to immunosuppressive medications in kidney transplant recipients at a referral center in Iran</p>. Patient Preference and Adherence. Volume 13. 729–738. 5 indexed citations
20.
Shafiekhani, Mojtaba, et al.. (2015). Prevalence of metabolic syndrome in adult population in Shiraz, southern Iran. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 9(3). 153–156. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fariba Samadian Breakdown of academic impact, for papers by Mojdeh S. Heavner Breakdown of academic impact, for papers by Claudia Gregoriano Breakdown of academic impact, for papers by Anne Leuppi-Taegtmeyer Breakdown of academic impact, for papers by Erika Jones Breakdown of academic impact, for papers by Jerry Altshuler Breakdown of academic impact, for papers by Molouk Hadjibabaie Breakdown of academic impact, for papers by Emmett Tsz Yeung Wong Breakdown of academic impact, for papers by Ali Taghizadeh Afshari Breakdown of academic impact, for papers by Shaun Eintracht
Rankless by CCL
2026